Regulation & governance

AstraZeneca’s heart drug failure raises a brutal question: how much treatment is too much treatment?

Alzheimer’s Treatment Moves Home. Risk Does Not.

Gonorrhoea Is Learning To Beat Ceftriaxone. Europe Must Move First.

Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing

Desmoid Tumours Are Not Benign to the People Living With Them

Pancreatic Cancer Is Forcing Regulators to Move Faster

Europe Built Seasonal COVID Campaigns. Most Older Adults Were Not Reached.

Ebola Has Passed 2,000 Cases. The Response Is Still Chasing It.

Treating hypertension in pregnancy is possible. Making it routine care is the policy challenge
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
